239 related articles for article (PubMed ID: 37122736)
41. Dynamic atlas of immune cells reveals multiple functional features of macrophages associated with progression of pulmonary fibrosis.
Lv J; Gao H; Ma J; Liu J; Tian Y; Yang C; Li M; Zhao Y; Li Z; Zhang X; Zhu Y; Zhang J; Wu L
Front Immunol; 2023; 14():1230266. PubMed ID: 37771586
[TBL] [Abstract][Full Text] [Related]
42. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO
Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491
[No Abstract] [Full Text] [Related]
43. Role of CD248 as a potential severity marker in idiopathic pulmonary fibrosis.
Bartis D; Crowley LE; D'Souza VK; Borthwick L; Fisher AJ; Croft AP; Pongrácz JE; Thompson R; Langman G; Buckley CD; Thickett DR
BMC Pulm Med; 2016 Apr; 16(1):51. PubMed ID: 27080864
[TBL] [Abstract][Full Text] [Related]
44. Identification of common signatures in idiopathic pulmonary fibrosis and lung cancer using gene expression modeling.
Leng D; Yi J; Xiang M; Zhao H; Zhang Y
BMC Cancer; 2020 Oct; 20(1):986. PubMed ID: 33046043
[TBL] [Abstract][Full Text] [Related]
45. The Combined Model of CX3CR1-Related Immune Infiltration Genes to Evaluate the Prognosis of Idiopathic Pulmonary Fibrosis.
Cai H; Chen S; Li X; Liu H; Zhang Y; Zhuang Q
Front Immunol; 2022; 13():837188. PubMed ID: 35222428
[TBL] [Abstract][Full Text] [Related]
46. TREM2 Insufficiency Protects against Pulmonary Fibrosis by Inhibiting M2 Macrophage Polarization.
Luo Q; Deng D; Li Y; Shi H; Zhao J; Qian Q; Wang W; Cai J; Yu W; Liu J
Int Immunopharmacol; 2023 May; 118():110070. PubMed ID: 37003186
[TBL] [Abstract][Full Text] [Related]
47. Transcriptomics in idiopathic pulmonary fibrosis unveiled: a new perspective from differentially expressed genes to therapeutic targets.
Hu W; Xu Y
Front Immunol; 2024; 15():1375171. PubMed ID: 38566986
[TBL] [Abstract][Full Text] [Related]
48. Cuproptosis-related gene CDKN2A as a molecular target for IPF diagnosis and therapeutics.
Xu B; Yang K; Han X; Hou J
Inflamm Res; 2023 Jun; 72(6):1147-1160. PubMed ID: 37166466
[TBL] [Abstract][Full Text] [Related]
49. Constructing an extracellular matrix-related prognostic model for idiopathic pulmonary fibrosis based on machine learning.
Luo H; Yan J; Zhou X
BMC Pulm Med; 2023 Oct; 23(1):397. PubMed ID: 37858084
[TBL] [Abstract][Full Text] [Related]
50. TGFβ1-RCN3-TGFBR1 loop facilitates pulmonary fibrosis by orchestrating fibroblast activation.
Wu M; Wang Z; Shi X; Zan D; Chen H; Yang S; Ding F; Yang L; Tan P; Ma RZ; Wang J; Ma L; Ma Y; Jin J
Respir Res; 2023 Sep; 24(1):222. PubMed ID: 37710230
[TBL] [Abstract][Full Text] [Related]
51. Establishment of the mouse model of acute exacerbation of idiopathic pulmonary fibrosis.
Wei YR; Qiu H; Wu Q; Du YK; Yin ZF; Chen SS; Jin YP; Zhao MM; Wang C; Weng D; Li HP
Exp Lung Res; 2016; 42(2):75-86. PubMed ID: 27070485
[TBL] [Abstract][Full Text] [Related]
52. Comprehensive gene expression profiling identifies distinct and overlapping transcriptional profiles in non-specific interstitial pneumonia and idiopathic pulmonary fibrosis.
Cecchini MJ; Hosein K; Howlett CJ; Joseph M; Mura M
Respir Res; 2018 Aug; 19(1):153. PubMed ID: 30111332
[TBL] [Abstract][Full Text] [Related]
53. Integrative analysis of lung molecular signatures reveals key drivers of idiopathic pulmonary fibrosis.
Kim SK; Jung SM; Park KS; Kim KJ
BMC Pulm Med; 2021 Dec; 21(1):404. PubMed ID: 34876074
[TBL] [Abstract][Full Text] [Related]
54. Ability of Periostin as a New Biomarker of Idiopathic Pulmonary Fibrosis.
Okamoto M; Izuhara K; Ohta S; Ono J; Hoshino T
Adv Exp Med Biol; 2019; 1132():79-87. PubMed ID: 31037627
[TBL] [Abstract][Full Text] [Related]
55. Bayesian probit regression model for the diagnosis of pulmonary fibrosis: proof-of-principle.
Meltzer EB; Barry WT; D'Amico TA; Davis RD; Lin SS; Onaitis MW; Morrison LD; Sporn TA; Steele MP; Noble PW
BMC Med Genomics; 2011 Oct; 4():70. PubMed ID: 21974901
[TBL] [Abstract][Full Text] [Related]
56. A Novel 5-Methylcytosine- and Immune-Related Prognostic Signature Is a Potential Marker of Idiopathic Pulmonary Fibrosis.
Huang T; Zhou HF
Comput Math Methods Med; 2022; 2022():1685384. PubMed ID: 36262873
[TBL] [Abstract][Full Text] [Related]
57. A prognostic model of idiopathic pulmonary fibrosis constructed based on macrophage and mitochondria-related genes.
Bao Y; Yang S; Zhao H; Wang Y; Li K; Liu X; Zhang W; Zhu X
BMC Pulm Med; 2024 Apr; 24(1):176. PubMed ID: 38609879
[TBL] [Abstract][Full Text] [Related]
58. Telomerase and telomere length in pulmonary fibrosis.
Liu T; Ullenbruch M; Young Choi Y; Yu H; Ding L; Xaubet A; Pereda J; Feghali-Bostwick CA; Bitterman PB; Henke CA; Pardo A; Selman M; Phan SH
Am J Respir Cell Mol Biol; 2013 Aug; 49(2):260-8. PubMed ID: 23526226
[TBL] [Abstract][Full Text] [Related]
59. Cellular Distribution of Secreted Phospholipase A2 in Lungs of IPF Patients and Its Inhibition in Bleomycin-Induced Pulmonary Fibrosis in Mice.
Jaiswal A; Rehman R; Dutta J; Singh S; Ray A; Shridhar M; Jaisankar J; Bhatt M; Khandelwal D; Sahoo B; Ram A; Mabalirajan U
Cells; 2023 Mar; 12(7):. PubMed ID: 37048117
[TBL] [Abstract][Full Text] [Related]
60. Aucuparin Suppresses Bleomycin-Induced Pulmonary Fibrosis Via Anti-Inflammatory Activity.
Lee SY; Park SY; Lee GE; Kim H; Kwon JH; Kim MJ; Yoon HG
J Med Food; 2021 Feb; 24(2):151-160. PubMed ID: 33512266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
